Novel pharmacological modulators of autophagy and therapeutic prospects

Bibliography

• Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010;22:124-31
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011;147:728-41
   PubMed Web of Science ®Google Scholar
• Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab 2011;13:495-504
   PubMed Web of Science ®Google Scholar
• Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010;40:280-93
   PubMed Web of Science ®Google Scholar
• Ravikumar B, Sarkar S, Davies JE, Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010;90:1383-435
   PubMed Web of Science ®Google Scholar
• Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 2012;19:87-95
   PubMed Web of Science ®Google Scholar
• Sridhar S, Botbol Y, Macian F, Cuervo AM. Autophagy and disease: always two sides to a problem. J Pathol 2012;226:255-73
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, Marino G, Kroemer G. Autophagy and aging. Cell 2011;146:682-95
   PubMed Web of Science ®Google Scholar
• Fleming A, Noda T, Yoshimori T, Rubinsztein DC. Chemical modulators of autophagy as biological probes and potential therapeutics. Nat Chem Biol 2011;7:9-17
   PubMed Web of Science ®Google Scholar
• Baek KH, Park J, Shin I. Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev 2012;41:3245-63
   PubMed Web of Science ®Google Scholar
• Alers S, Loffler AS, Wesselborg S, Stork B. The incredible ULKs. Cell Commun Signal 2012;10:7
   PubMed Web of Science ®Google Scholar
• Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010;40:310-22
   PubMed Web of Science ®Google Scholar
• Laplante M. Sabatini DM. mTOR signaling in growth control and disease. Cell 2012;149:274-93
   PubMed Web of Science ®Google Scholar
• Alers S, Loffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012;32:2-11
   PubMed Web of Science ®Google Scholar
• Yeda Research and Development Co Ltd. Death associated protein 1 variants and use thereof for modulating autophagy. WO2011111051; 2011
   Google Scholar
• Koren I, Reem E, Kimchi A. DAP1, a novel substrate of mTOR, negatively regulates autophagy. Curr Biol 2010;20:1093-8
   PubMed Web of Science ®Google Scholar
• Fondazione Telethon. Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof. WO2010092112; 2010
   Google Scholar
• Settembre C, Zoncu R, Medina DL, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 2012;31:1095-108
   PubMed Web of Science ®Google Scholar
• Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011;18:571-80
   PubMed Web of Science ®Google Scholar
• Di Bartolomeo S, Corazzari M, Nazio F, The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol 2010;191:155-68
   PubMed Web of Science ®Google Scholar
• Mount Sinai School of Medicine of NYU, The Rockefeller University. Novel autophagy regulators Atg14L and Rubicon. WO2010030936; 2010
   Google Scholar
• Sun Q, Zhang J, Fan W, The RUN domain of rubicon is important for hVps34 binding, lipid kinase inhibition, and autophagy suppression. J Biol Chem 2011;286:185-91
   PubMed Web of Science ®Google Scholar
• Lipinski MM, Hoffman G, Ng A, A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev Cell 2010;18:1041-52
   PubMed Web of Science ®Google Scholar
• President and Fellows of Harvard College. Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products. WO2011041584; 2011
   Google Scholar
• President and Fellows of Harvard College. Methods for modulation of autophagy through the modulation of autophagy-inhibiting gene products. WO2011041582; 2011
   Google Scholar
• Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 2011;8:108-17
   PubMed Web of Science ®Google Scholar
• Hidvegi T, Ewing M, Hale P, An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 2010;329:229-32
   PubMed Web of Science ®Google Scholar
• Lefranc F, Ingrassia L, Kiss R. Targeting autophagy: do patents reveal a therapeutic potential? Expert Opin Ther Patents 2008;18:813-19
   Web of Science ®Google Scholar
• Nyfeler B, Bergman P, Triantafellow E, Relieving autophagy and 4EBP1 from rapamycin resistance. Mol Cell Biol 2011;31:2867-76
   PubMed Web of Science ®Google Scholar
• Chresta CM, Davies BR, Hickson I, AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res 2010;70:288-98
   PubMed Web of Science ®Google Scholar
• Fan QW, Cheng C, Hackett C, Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 2010;3:ra81
   PubMed Web of Science ®Google Scholar
• The Salk Institute for Biological Studies. ULK1 compositions, inhibitors, screening and methods of use. WO2011084523; 2011
   Google Scholar
• Vingtdeux V, Chandakkar P, Zhao H, Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation. FASEB J 2011;25:219-31
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Le Toumelin G, Criollo A, Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007;26:2527-39
   PubMed Web of Science ®Google Scholar
• Chipuk JE, Moldoveanu T, Llambi F, The BCL-2 family reunion. Mol Cell 2010;37:299-310
   PubMed Web of Science ®Google Scholar
• University of Florida Research Foundation. Methods and compositions for the treatment of cancers and pathogenic infections. WO2011019636; 2011
   Google Scholar
• Oberstein A, Jeffrey PD, Shi Y. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: beclin 1 is a novel BH3-only protein. J Biol Chem 2007;282:13123-32
   PubMed Web of Science ®Google Scholar
• Fondazione Santa Lucia. Peptidic and peptidomimetic compounds for regulating autophagy. WO2010018182; 2010
   Google Scholar
• Vergne I, Deretic V. The role of PI3P phosphatases in the regulation of autophagy. FEBS Lett 2010;584:1313-18
   PubMed Web of Science ®Google Scholar
• Van Andel Research Institute. Method for treating autophagy-related disorders. WO2010129681; 2010
   Google Scholar
• Eisenberg T, Knauer H, Schauer A, Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009;11:1305-14
   PubMed Web of Science ®Google Scholar
• Katholieke Universiteit Leuven. Polyamine activators (spermine, spermidine) of the autophagic pathway. WO2010081204; 2010
   Google Scholar
• Morselli E, Marino G, Bennetzen MV, Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol 2011;192:615-29
   PubMed Web of Science ®Google Scholar
• President and Fellows of Harvard College, Dana Farber Cancer Institute, Cambridge Enterprise Ltd. Regulating autophagy. WO2008122038; 2008
   Google Scholar
• Sarkar S, Perlstein EO, Imarisio S, Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007;3:331-8
   PubMed Web of Science ®Google Scholar
• Tian Y, Bustos V, Flajolet M, Greengard P. A small-molecule enhancer of autophagy decreases levels of Abeta and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 2011;25:1934-44
   PubMed Web of Science ®Google Scholar
• Floto RA, Sarkar S, Perlstein EO, Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 2007;3:620-2
   PubMed Web of Science ®Google Scholar
• President and Fellows of Harvard College, Shangai Institute of organic chemistry. Autophagy inducing compounds and uses thereof in treating autophagy associated diseases. WO2009049242; 2009
   Google Scholar
• Zhang L, Yu J, Pan H, Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci USA 2007;104:19023-8
   PubMed Web of Science ®Google Scholar
• President and Fellows of Harvard College, Shanghai Institute of Organic Chemistry. Diphenylbutypiperidine autophagy inducers. WO2011143444; 2011
   Google Scholar
• Xia HG, Zhang L, Chen G, Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy 2010;6:61-6
   PubMed Web of Science ®Google Scholar
• Cambridge Enterprise Ltd. Modulation of autophagy by calpain inhibition. WO2007003941; 2007
   Google Scholar
• Tsvetkov AS, Miller J, Arrasate M, A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci USA 2010;107:16982-7
   PubMed Web of Science ®Google Scholar
• Bedia C, Levade T, Codogno P. Regulation of autophagy by sphingolipids. Anticancer Agents Med Chem 2011;11:844-53
   Google Scholar
• Apogee Biotechnology Corp. X. Sphingosine kinase inhibitors. US8063248; 2011
   Google Scholar
• Beljanski V, Knaak C, Smith CD. A novel sphingosine kinase inhibitor induces autophagy in tumor cells. J Pharmacol Exp Ther 2010;333:454-64
   Google Scholar
• Young M, Takahashi Y, Khan O, Autophagosomal membrane serves as a platform for an intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J Biol Chem 2012;287:12455-1268
   PubMed Web of Science ®Google Scholar
• Beljanski V, Knaak C, Zhuang Y, Smith CD. Combined anticancer effects of sphingosine kinase inhibitors and sorafenib. Invest New Drugs 2011;29:1132-42
   PubMed Web of Science ®Google Scholar
• ABC294640 in treating patients with advanced solid tumors (ABC-101). Available from: http://clinicaltrials.gov/ct2/results?term=abc294640 [Last accessed 17 July 2012]
   Google Scholar
• Novogen Research PTY Ltd. Method for inducing autophagy. WO2008113100; 2008
   Google Scholar
• Alvero AB, Montagna MK, Chen R, NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway. Cancer 2009;115:3204-16
   PubMed Web of Science ®Google Scholar
• Alvero AB, Montagna MK, Holmberg JC, Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther 2011;10:1385-93
   PubMed Web of Science ®Google Scholar
• Marshall Edwards announces first cohort of patients dosed in Phase I clinical trial of oncology drug candidate ME-344. Available from: http://www.meipharma.com/news/2012/05/29/ Last accessed 17 July 2012]
   Google Scholar
• Lee JS, Li Q, Lee JY, FLIP-mediated autophagy regulation in cell death control. Nat Cell Biol 2009;11:1355-62
   PubMed Web of Science ®Google Scholar
• University of Southern California. FLIP death effector domain derived peptides for inducing autophagy. WO201011952; 2010
   Google Scholar
• University of Southern California. Highly potent peptides to control cancer and neurodegenerative diseases. WO20120158386; 2012
   Google Scholar
• Tormo D, Checinska A, Alonso-Curbelo D, Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 2009;16:103-14
   PubMed Web of Science ®Google Scholar
• Fundacion Centro Nacional de investigaciones oncolgicas Carlos III. Process for the identification of compounds for treating cancer. WO2011003883; 2011
   Google Scholar
• Elgendy M, Sheridan C, Brumatti G, Martin SJ. Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 2011;42:23-35
   PubMed Web of Science ®Google Scholar
• Tang Y, Hamed HA, Cruickshanks N, Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol 2012;81:527-40
   PubMed Web of Science ®Google Scholar
• Inao T, Harashima N, Monma H, Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer. Breast Cancer Res Treat 2012;134:89-100
   PubMed Web of Science ®Google Scholar
• Clark PE. The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. Kidney Int 2009;76:939-45
   PubMed Web of Science ®Google Scholar
• Leland Stanford Junior University, Auckland Uniservices Ltd. Heteroaryl compounds, compositions, and methods of use in cancer treatment. WO2009114552; 2009
   Google Scholar
• Turcotte S, Chan DA, Sutphin PD, A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 2008;14:90-102
   PubMed Web of Science ®Google Scholar
• Anbalagan S, Pires IM, Blick C, Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy. Radiother Oncol 2012;103:388-93
   PubMed Web of Science ®Google Scholar
• Hay MP, Turcotte S, Flanagan JU, 4-Pyridylanilinothiazoles that selectively target von Hippel-Lindau deficient renal cell carcinoma cells by inducing autophagic cell death. J Med Chem 2010;53:787-97
   PubMed Web of Science ®Google Scholar
• Bonnet M, Flanagan JU, Chan DA, SAR studies of 4-pyridyl heterocyclic anilines that selectively induce autophagic cell death in von Hippel-Lindau-deficient renal cell carcinoma cells. Bioorg Med Chem 2011;19:3347-56
   PubMed Web of Science ®Google Scholar
• Butler D, Hwang J, Estick C, Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One 2011;6:e20501
   Web of Science ®Google Scholar
• University of Connecticut. Compounds for lysosomal modulation and methods of use. WO2009129532; 2009
   Google Scholar
• Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011;8:528-39
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Lippincott-Schwartz J, Yin XM, Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011;17:654-66
   PubMed Web of Science ®Google Scholar
• Eng CH, Abraham RT. The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming. Oncogene 2011;30:4687-96
   PubMed Web of Science ®Google Scholar
• The University of Medicine and Dentistry of New Jersey. Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor. WO20110022236; 2010
   Google Scholar
• US Department of Health and Human Services. Disabling autophagy as a treatment for lysosomal storage diseases. WO2011028941; 2011
   Google Scholar
• Mount Sinai School of Medicine. Methods and compositions for inhibiting autophagy for the treatment of fibrosis. WO2012037547; 2012
   Google Scholar
• Miller S, Tavshanjian B, Oleksy A, Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 2010;327:1638-42
   PubMed Web of Science ®Google Scholar
• Novartis AG. Bi-heteroaryl compounds as vps34 inhibitors. WO2012085815; 2012
   Google Scholar
• Zhu H, Wu H, Li X, Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009;5:816-23
   PubMed Web of Science ®Google Scholar
• Korkmaz G, le Sage C, Tekirdag KA, miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy 2012;8:165-76
   PubMed Web of Science ®Google Scholar
• Sabanci Universitesi. Use of miRNAs for the diagnosis, prophylaxis, treatment and follow-up of diseases involving macroautophagy abnormalities. WO2012044265; 2012
   Google Scholar
• McDermott AM, Heneghan HM, Miller N, Kerin MJ. The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm Res 2011;28:3016-29
   Google Scholar
• President and Fellows of Harvard College, Shangai Institute of organic chemistry. Potent small molecule inhibitors of autophagy, and methods of use thereof. WO2011011522; 2011
   Google Scholar
• Liu J, Xia H, Kim M, Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011;147:223-34
   PubMed Web of Science ®Google Scholar
• Tanida I, Sou YS, Ezaki J, HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates. J Biol Chem 2004;279:36268-76
   PubMed Web of Science ®Google Scholar
• Li M, Hou Y, Wang J, Kinetics comparisons of mammalian Atg4 homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem 2011;286:7327-38
   PubMed Web of Science ®Google Scholar
• University of Florida Research Foundation. Methods and compositions for the treatment of cancers and pathogenic infections. WO2009089147; 2009
   Google Scholar
• Kumanomidou T, Mizushima T, Komatsu M, The crystal structure of human Atg4b, a processing and de-conjugating enzyme for autophagosome-forming modifiers. J Mol Biol 2006;355:612-18
   PubMed Web of Science ®Google Scholar
• Satoo K, Noda NN, Kumeta H, The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy. EMBO J 2009;28:1341-50
   PubMed Web of Science ®Google Scholar
• Shu CW, Madiraju C, Zhai D, High-throughput fluorescence assay for small-molecule inhibitors of autophagins/Atg4. J Biomol Screen 2011;16:174-82
   PubMedGoogle Scholar
• Li M, Chen X, Ye QZ, A high-throughput FRET-based assay for determination of Atg4 activity. Autophagy 2012;8:401-12
   PubMed Web of Science ®Google Scholar
• San Diego State University Foundation. Compositions and methods for modulating autophagy. WO2011106684; 2011
   Google Scholar
• Gottlieb RA, Mentzer RMJ. Cardioprotection through autophagy: ready for clinical trial? Autophagy 2011;7:434-5
   PubMed Web of Science ®Google Scholar
• The University of British Columbia. Autophagy inhibitor compounds, compositions and methods for the use thereof in the treatment of cancer. WO2011017809; 2011
   Google Scholar
• Donohue E, Tovey A, Vogl AW, Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J Biol Chem 2011;286:7290-300
   PubMed Web of Science ®Google Scholar
• The General Hospital Corp. Autophagic compounds and tyrosine kinase inhibitors for treating cancer. WO2008036254; 2008
   Google Scholar
• University of Colorado. Methods and products for treating proliferative diseases. WO2010008554; 2010
   Google Scholar
• The Trustees of the University of Pennsylvania. Combination antineoplastic therapy. WO2010132233; 2010
   Google Scholar
• Exelixis, Inc., The Regents of the University of California. Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K amd mTOR in combination with autophagy inhibitors. WO2011100319; 2011
   Google Scholar
• Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms. WO2012087336; 2012
   Google Scholar
• Maycotte P, Aryal S, Cummings CT, Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 2012;8:200-12
   PubMed Web of Science ®Google Scholar
• Amaravadi R. Autophagy inhibition in cancer therapy: progress and unaswered questions. AAAS Annual Meeting 16-20 February 2012. Vancouver, Canada. Available from: http://aaas.confex.com/aaas/2012/webprogram/Paper6717.html [Last accessed 17 July 2012]
   Google Scholar
• McAfee Q, Zhang Z, Samanta A, Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA 2012;109:8253-8
   PubMed Web of Science ®Google Scholar
• Naidu MD, Mason JM, Pica RV, Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. J Radiat Res (Tokyo) 2010;51:393-404
   PubMed Web of Science ®Google Scholar
• Spectrum Pharmaceuticals, Inc Thioxantone-based autophagy inhibitor therapies to treat cancer. WO2011112623; 2011
   Google Scholar
• Carew JS, Espitia CM, Esquivel JA, Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. J Biol Chem 2011;286:6602-13
   PubMed Web of Science ®Google Scholar
• Safety and efficacy study of lucanthone when used in combination with temozolomide(TMZ) and radiation to treat glioblastoma multiforme(GBM). Available from: http://clinicaltrials.gov/ct2/results?term=lucanthone [Last accessed 17 July 2012]
   Google Scholar
• University of Manitoba. The use of glycosylated antitumor ether lipids to induce and/or enhance autophagy for treatment of diseases. WO2009092170; 2009
   Google Scholar
• Jahreiss L, Renna M, Bittman R, 1-O-Hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol (Gln) induces cell death with more autophagosomes which is autophagy-independent. Autophagy 2009;5:835-46
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010;466:68-76
   PubMed Web of Science ®Google Scholar
• Lipinski MM, Zheng B, Lu T, Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci USA 2010;107:14164-9
   PubMed Web of Science ®Google Scholar
• Nixon RA, Yang DS. Autophagy failure in Alzheimer's disease–locating the primary defect. Neurobiol Dis 2011;43:38-45
   PubMed Web of Science ®Google Scholar
• Duke University. Therapeutic agents for neurodegenerative diseases. WO2011066430; 2011
   Google Scholar
• Pandey UB, Nie Z, Batlevi Y, HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007;14:859-63
   Google Scholar
• Gonzalez P, Mader I, Tchoghandjian A, Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process. Cell Death Differ 2012;19:1337-46
   PubMed Web of Science ®Google Scholar
• Reggiori F, Komatsu M, Finley K, Simonsen A. Autophagy: more than a nonselective pathway. Int J Cell Biol 2012;2012:219625
   PubMedGoogle Scholar
• Juenemann K, Reits EA. Alternative macroautophagic pathways. Int J Cell Biol 2012;2012:189794
   PubMedGoogle Scholar
• Codogno P, Mehrpour M, Proikas-Cezanne T. Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol 2012;13:7-12
   PubMed Web of Science ®Google Scholar
• Edelmann MJ, Nicholson B, Kessler BM. Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases. Expert Rev Mol Med 2011;13:e35
   PubMed Web of Science ®Google Scholar
• Hamai A, Codogno P. New targets for acetylation in autophagy. Sci Signal 2012;5:pe29
   PubMed Web of Science ®Google Scholar
• Czaja MJ. Functions of autophagy in hepatic and pancreatic physiology and disease. Gastroenterology 2011;140:1895-908
   PubMed Web of Science ®Google Scholar
• Nemchenko A, Chiong M, Turer A, Autophagy as a therapeutic target in cardiovascular disease. J Mol Cell Cardiol 2011;51:584-93
   Google Scholar
• Sandri M. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am J Physiol Cell Physiol 2010;298:C1291-7
   Google Scholar
• Czaja MJ. Autophagy in health and disease. 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications. Am J Physiol Cell Physiol 2010;298:C973-8
   PubMed Web of Science ®Google Scholar
• Kovsan J, Bluher M, Tarnovscki T, Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab 2011;96:E268-77
   PubMed Web of Science ®Google Scholar
• Fujitani Y, Ueno T, Watada H. Autophagy in health and disease. 4. The role of pancreatic beta-cell autophagyin health and diabetes. Am J Physiol Cell Physiol 2010;299:C1-6
   Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature 2011;469:323-35
   PubMed Web of Science ®Google Scholar
• Yeda Research and Development Co Ltd. Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to Beclin-1. WO2010064250; 2010
   Google Scholar
• University of Rochester. Methods and compositions related to modulating autophagy. WO2011146879; 2011
   Google Scholar
• Available from: http://www.bioncotech.com/es/ [Last accessed 17 July 2012]
   Google Scholar
• Available from: http://www.rugacorp.com/Pipeline.html [Last accessed 17 July 2012]
   Google Scholar
• Jaber N, Dou Z, Chen JS, Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci USA 2012;109:2003-8
   PubMed Web of Science ®Google Scholar
• Ktistakis NT, Manifava M, Schoenfelder P, Rotondo S. How phosphoinositide 3-phosphate controls growth downstream of amino acids and autophagy downstream of amino acid withdrawal. Biochem Soc Trans 2012;40:37-43
   Google Scholar
• Cosford N. Targeting kinases regulating sensitivity to anti-estrogens and autophagy. Available from: http://sanfordburnham.flintbox.com/public/project/19714/ [Last accessed 17 July 2012]
   Google Scholar
• Young RN, Arns S, Gorski SM, Novel assays and inhibitors of the key autophagy protease. AAAS Annual Meeting 16-20 February 2012. Vancouver, Canada. Available from: http://aaas.confex.com/aaas/2012/webprogram/Paper6715.html [Last accessed 17 July 2012]
   Google Scholar
• Noda NN, Satoo K, Fujioka Y, Structural basis of Atg8 activation by a homodimeric E1, Atg7. Mol Cell 2011;44:462-75
   PubMed Web of Science ®Google Scholar
• Taherbhoy AM, Tait SW, Kaiser SE, Atg8 transfer from Atg7 to Atg3: a distinctive E1-E2 architecture and mechanism in the autophagy pathway. Mol Cell 2011;44:451-61
   PubMed Web of Science ®Google Scholar
• D'Amore N. Autophagy research: an industrial perspective. AAAS Annual Meeting 16-20 February 2012. Vancouver, Canada. Available from: http://aaas.confex.com/aaas/2012/webprogram/Paper6616.html [Last accessed 17 July 2012]
   Google Scholar